Herbalife Analyst Price Targets - Benzinga

Herbalife Ltd

HLFNYSE

Trade with Public

Trade with Public

$12.50

-0.06-0.48%

Últ. Act.: Oct 5, 4:00 PM

$12.50

-0.06-0.48%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

Herbalife Analyst Price Targets - Benzinga

Herbalife Analyst Price Targets

Wall Street analyst price targets and consensus rating for Herbalife (HLF).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

5Buy

2Hold

1Sell

Consensus RatingBuy# Analysts8Avg. Consensus PT$15Upside to Avg. PT+16.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Citigroup	Chasen Bender	PT Cut	Buy	$21→$17
Apr 28, 2026	RBC Capital	Ryland Conrad	PT Cut	Sector Perform	$17→$16
Mar 30, 2026	Mizuho	John Baumgartner	PT Raise	Neutral	$13→$15
Feb 19, 2026	Citigroup	Chasen Bender	PT Raise	Buy	$17→$21
Jan 8, 2026	Mizuho	John Baumgartner	PT Raise	Neutral	$11→$13
Jan 6, 2026	Maxim Group	Anthony Vendetti	Initiate	Buy	$20
Dec 12, 2025	Citigroup	Chasen Bender	PT Raise	Buy	$11→$17
Nov 26, 2025	Mizuho	John Baumgartner	PT Raise	Neutral	$10→$11
Nov 26, 2025	Argus Research	John Staszak	Upgrade	Hold→Buy	—
Jul 28, 2025	Mizuho	John Baumgartner	PT Raise	Neutral	$8→$9
May 1, 2025	Citigroup	Chasen Bender	PT Cut	Buy	$13→$11
Mar 21, 2025	DA Davidson	Linda Bolton Weiser	Upgrade	Neutral→Buy	$8→$14
Feb 20, 2025	DA Davidson	Linda Bolton Weiser	Maintained	Neutral	$8
Nov 1, 2024	Mizuho	John Baumgartner	PT Raise	Neutral	$8→$9
Oct 31, 2024	DA Davidson	Linda Bolton Weiser	PT Cut	Neutral	$13→$8
Oct 31, 2024	B. Riley Securities	Jeff Van Sinderen	PT Cut	Buy	$17→$12
Oct 25, 2024	Citigroup	Chasen Bender	PT Cut	Buy	$16→$13
Aug 1, 2024	B. Riley Securities	Jeff Van Sinderen	PT Raise	Buy	$16→$17
Aug 1, 2024	DA Davidson	Linda Bolton Weiser	PT Raise	Neutral	$10→$13
Jun 7, 2024	Mizuho	John Baumgartner	PT Raise	Neutral	$10→$11

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citigroup Maintains Buy on Herbalife, Lowers Price Target to $17

Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and lowers the price target from $21 to $17.

Benzinga Newsdesk

Bill Ackman's 'Baby Buffett' Model Is 'Democratizing Hedge Fund Owneship,' Analyst Says

BofA initiated Pershing Square with a Neutral rating, calling Bill Ackman's firm a "Baby Buffett" model built on permanent capital, retail investing access and long-term compounding.

Piero Cingari

PRO
Mizuho Maintains Neutral on Herbalife, Raises Price Target to $15

Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $13 to $15.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Herbalife, Raises Price Target to $21

Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and raises the price target from $17 to $21.

Benzinga Newsdesk

PRO
Mizuho Maintains Neutral on Herbalife, Raises Price Target to $13

Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $11 to $13.

Benzinga Newsdesk

PRO
Maxim Group Initiates Coverage On Herbalife with Buy Rating, Announces Price Target of $20

Maxim Group analyst Anthony Vendetti initiates coverage on Herbalife (NYSE:HLF) with a Buy rating and announces Price Target of $20.

Benzinga Newsdesk